Express Pharma
DECEMBER 11, 2024
billion in 2030, with the pediatric and adult segments accounting for $2.2 Six more products in late-stage development have potential to launch by 2030. Various unmet needs are expected to be addressed over the forecast period, including more prophylactic options across the different patient segments, as well as combination vaccines.
STAT
MAY 19, 2023
Now, 20 years later, we have a cure for hepatitis C and a highly effective vaccine and treatment for hepatitis B — but annual deaths from the two are projected to outnumber deaths from HIV, tuberculosis, and malaria combined by 2040. Viral hepatitis affects almost 400 million people and kills more than 1 million each year.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
FEBRUARY 12, 2024
Novo Holdings, the controlling shareholder of Novo Nordisk, plans to invest about $35 billion by 2030 , Reuters writes. Novo Holdings would invest about $5 billion a year in the next five years, and that could go up to $7 billion a year by 2030.
STAT
SEPTEMBER 29, 2022
The Covid-19 pandemic set back many of the global health goals for 2030. One of the most feasible to recover is the target of eliminating human deaths from rabies , thanks to an effective, inexpensive vaccine for dogs.
STAT
JANUARY 12, 2023
SAN FRANCISCO — When BioNTech was founded in 2008, messenger RNA therapies and vaccines were still an unproven idea. The German company has now shipped out billions of doses of its mRNA Covid-19 vaccine worldwide — and BioNTech’s leaders say that’s just the beginning of a larger revolution in medicine.
pharmaphorum
OCTOBER 26, 2020
Strategies include different options focused on health maintenance, such as vaccination programmes, smoking cessation services, support for physical activity, and access to technologies that support early detection of diseases. How could payer views change by 2030? Understanding payer views of preventive care.
The Guardian - Pharmaceutical Industry
OCTOBER 16, 2022
ahin and Özlem Türeci say mRNA Covid vaccine technology could be repurposed to help destroy cancer cells Vaccines that target cancer could be available before the end of the decade, according to the husband and wife team behind one of the most successful Covid vaccines of the pandemic. Continue reading.
Expert insights. Personalized for you.
102 
Let's personalize your content